These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15897955)

  • 1. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.
    Dickerson BC; Sperling RA
    NeuroRx; 2005 Apr; 2(2):348-60. PubMed ID: 15897955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers for early detection and pharmacological treatment of Alzheimer's disease.
    Hampel H; Broich K; Hoessler Y; Pantel J
    Dialogues Clin Neurosci; 2009; 11(2):141-57. PubMed ID: 19585950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in structural and molecular neuroimaging in Alzheimer's disease.
    Ellis KA; Rowe CC; Szoeke CE; Villemagne VL; Ames D; Chételat G; Martins RN; Masters CL; Fripp J; Acosta O; Raniga P; Bourgeat PT; Salvado O
    Med J Aust; 2011 Feb; 194(4):S20-3. PubMed ID: 21401483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
    Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Biomarkers in Alzheimer's Disease Drug Development.
    Cummings J
    Adv Exp Med Biol; 2019; 1118():29-61. PubMed ID: 30747416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of neuroimaging to disease-modification trials in Alzheimer's disease.
    Fleisher AS; Donohue M; Chen K; Brewer JB; Aisen PS;
    Behav Neurol; 2009; 21(1):129-36. PubMed ID: 19847051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
    Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
    Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies.
    Seibyl J; Zubal IG; Jennings D; Marek K; Doraiswamy PM
    Expert Rev Neurother; 2011 Dec; 11(12):1783-93. PubMed ID: 22091601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
    Thal DR; Attems J; Ewers M
    J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians].
    Trombella S; Assal F; Zekry D; Gold G; Giannakopoulos P; Garibotto V; Démonet JF; Frisoni GB
    Rev Med Suisse; 2016 Apr; 12(515):795-8. PubMed ID: 27276723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging to assess safety and efficacy of AD therapies.
    Hill D
    Expert Opin Investig Drugs; 2010 Jan; 19(1):23-6. PubMed ID: 19947893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alzheimer's disease neuroimaging initiative.
    Mueller SG; Weiner MW; Thal LJ; Petersen RC; Jack C; Jagust W; Trojanowski JQ; Toga AW; Beckett L
    Neuroimaging Clin N Am; 2005 Nov; 15(4):869-77, xi-xii. PubMed ID: 16443497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Alzheimer's disease drug development.
    Cummings JL
    Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the validation of functional neuroimaging as a potential biomarker for Alzheimer's disease: implications for drug development.
    Pupi A; Mosconi L; Nobili FM; Sorbi S
    Mol Imaging Biol; 2005; 7(1):59-68. PubMed ID: 15912277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.
    Khan TK; Alkon DL
    J Alzheimers Dis; 2015; 46(4):817-36. PubMed ID: 26402622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for Alzheimer's disease therapeutic trials.
    Hampel H; Wilcock G; Andrieu S; Aisen P; Blennow K; Broich K; Carrillo M; Fox NC; Frisoni GB; Isaac M; Lovestone S; Nordberg A; Prvulovic D; Sampaio C; Scheltens P; Weiner M; Winblad B; Coley N; Vellas B;
    Prog Neurobiol; 2011 Dec; 95(4):579-93. PubMed ID: 21130138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.
    Malpas CB; Vivash L; Genc S; Saling MM; Desmond P; Steward C; Hicks RJ; Callahan J; Brodtmann A; Collins S; Macfarlane S; Corcoran NM; Hovens CM; Velakoulis D; O'Brien TJ
    J Alzheimers Dis; 2016 Jul; 54(1):223-32. PubMed ID: 27447428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of effective biomarkers for Alzheimer's disease: a review.
    Henry MS; Passmore AP; Todd S; McGuinness B; Craig D; Johnston JA
    Int J Geriatr Psychiatry; 2013 Apr; 28(4):331-40. PubMed ID: 22674539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.